Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance

por Pu, Xingxiang, Wu, Lin, Su, Dan, Mao, Weimin, Fang, Bingliang
Publicado 2018

Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials

por Yu, Shaofu, Zhai, Shasha, Gong, Qian, Xiang, Chunhong, Gong, Jianping, Wu, Lin, Pu, Xingxiang
Publicado 2023

miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9

por WU, LIN, PU, XINGXIANG, WANG, QIANZHI, CAO, JUN, XU, FANG, XU, LI, LI, KANG
Publicado 2016

Case Report: Tissue Origin Identification for Cancer of Unknown Primary: Gene Expression Profiling Approach

por Pu, Xingxiang, Yang, Sa, Xu, Yan, Chen, Bolin, Wang, Qianzhi, Gong, Qian, Wu, Lin
Publicado 2021

A real‐world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non‐small cell lung cancer

por Zhang, Baihua, Xiao, Haifan, Pu, Xingxiang, Zhou, Chunhua, Yang, Desong, Li, Xu, Wang, Wenxiang, Xiao, Qin
Publicado 2022

Association of microRNA-423 rs6505162 C>A polymorphism with susceptibility and metastasis of colorectal carcinoma

por Jia, Wenrui, Zeng, Liuyan, Luo, Shengqun, Bai, Fei, Zhong, Rui, Wu, Lin, Huang, Guo-Liang, Pu, Xingxiang
Publicado 2018

Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study

por Pu, Xingxiang, Zhou, Yu, Kong, Yi, Chen, Bolin, Yang, Aifang, Li, Jia, Li, Kang, Xu, Yan, Wu, Lin
Publicado 2023

Computed tomography-based radiomics quantification predicts epidermal growth factor receptor mutation status and efficacy of first-line targeted therapy in lung adenocarcinoma

por Jiang, Meilin, Yang, Pei, Li, Jing, Peng, Wenying, Pu, Xingxiang, Chen, Bolin, Li, Jia, Wang, Jingyi, Wu, Lin
Publicado 2022

Perivascular epithelioid cell tumor of the lung: A case report and literature review

por Yu, Shaofu, Zhai, Shasha, Gong, Qian, Hu, Xiaoping, Yang, Wenjuan, Liu, Liyu, Kong, Yi, Wu, Lin, Pu, Xingxiang
Publicado 2022

Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Case-Control Study and Meta-Analysis

por Liao, Dan, Wu, Yongfu, Pu, Xingxiang, Chen, Hua, Luo, Shengqun, Li, BinBin, Ding, Congcong, Huang, Guo-Liang, He, Zhiwei
Publicado 2014

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

por Cao, Xiaobo, Zhao, Yang, Wang, Jing, Dai, Bingbing, Gentile, Emanuela, Lin, Jing, Pu, Xingxiang, Ji, Lin, Wu, Shuhong, Meraz, Ismail, Majidi, Mourad, Roth, Jack A.
Publicado 2017

High‐throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion

por Song, Zhengbo, Xu, Chunwei, Pu, Xingxiang, Zhu, Youcai, Wang, Wenxian, Li, Xingliang, Gao, Yanqiu, Zhu, Wenliang, He, Yunwei, Wu, Lin, Mao, Li, Chen, Li, Chen, Ming
Publicado 2021

Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study

por Chen, Meiting, Chen, Yungchang, Fang, Xiaojie, Wang, Zhao, Pu, Xingxiang, Liang, Chaoyong, Guo, Hongqiang, Li, Qian, Pan, Fei, Hong, Huangming, Huang, He, Li, Jiman, Lin, Tongyu
Publicado 2022

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy

por Jiang, Meilin, Peng, Wenying, Pu, Xingxiang, Chen, Bolin, Li, Jia, Xu, Fang, Liu, Liyu, Xu, Li, Xu, Yan, Cao, Jun, Wang, Qianzhi, Li, Kang, Wang, Jingyi, Wu, Lin
Publicado 2020

The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell...

por Chen, Bolin, Wang, Jingyi, Pu, Xingxiang, Li, Jia, Wang, Qianzhi, Liu, Liyu, Xu, Yan, Xu, Li, Kong, Yi, Li, Kang, Xu, Fang, Liang, Shuzhi, Cardona, Andrés F., Wu, Lin
Publicado 2022

Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study

por Pu, Xingxiang, Wang, QianZhi, Liu, Liyu, Chen, Bolin, Li, Kang, Zhou, Yu, Sheng, Zengmei, Liu, Ping, Tang, Yucheng, Xu, Li, Li, Jia, Kong, Yi, Xu, Fang, Xu, Yan, Wu, Lin
Publicado 2022

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

por Pu, Xingxiang, Zhang, Ran, Wang, Li, Chen, Yungchang, Xu, Yi, Pataer, Apar, Meraz, Ismail M., Zhang, Xiaoshan, Wu, Shuhong, Wu, Lin, Su, Dan, Mao, Weimin, Heymach, John V., Roth, Jack A., Swisher, Stephen G., Fang, Bingliang
Publicado 2018

Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

por Hu, Xingsheng, Yang, Dongyong, Li, Yalun, Li, Li, Wang, Yan, Chen, Peng, Xu, Song, Pu, Xingxiang, Zhu, Wei, Deng, Pengbo, Ye, Junyi, Zhang, Hanhan, Lizaso, Analyn, Liu, Hao, Mao, Xinru, Huang, Hai, Chu, Qian, Hu, Chengping
Publicado 2019

Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

por Hu, Xingsheng, Yang, Dongyong, Li, Yalun, Li, Li, Wang, Yan, Chen, Peng, Xu, Song, Pu, Xingxiang, Zhu, Wei, Deng, Pengbo, Ye, Junyi, Zhang, Hanhan, Lizaso, Analyn, Liu, Hao, Mao, Xinru, Huang, Hai, Chu, Qian, Hu, Chengping
Publicado 2020

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)

por Peng, Wenying, Cao, Liming, Chen, Likun, Lin, Gen, Zhu, Bo, Hu, Xiaohua, Lin, Yingcheng, Zhang, Sheng, Jiang, Meilin, Wang, Jingyi, Li, Junjun, Li, Chao, Shao, Lin, Du, Haiwei, Hou, Ting, Chen, Zhiqiu, Xiang, Jianxing, Pu, Xingxiang, Li, Jia, Xu, Fang, Loong, Herbert, Wu, Lin
Publicado 2022